Insider · CIK 0001854126

Garren Hideki

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001854126

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-02-27	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+85K sh	—	—	85,000
2024-01-01	COYACoya Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-09-13	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,000 sh	$24.90	+$49.8K	2,000
2023-09-13	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−2,000 sh	$55.48	−$111K	0
2023-09-13	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,000 sh	—	—	192,000
2023-08-16	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,000 sh	$24.90	+$49.8K	2,000
2023-08-16	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−878 sh	$58.15	−$51.1K	1,122
2023-08-16	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−748 sh	$58.93	−$44.1K	374
2023-08-16	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−374 sh	$59.74	−$22.3K	0
2023-08-16	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,000 sh	—	—	194,000
2023-07-12	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+2,000 sh	$24.90	+$49.8K	2,000
2023-07-12	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−1,908 sh	$67.48	−$129K	92
2023-07-12	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−92 sh	$68.20	−$6,274.004	0
2023-07-12	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−2,000 sh	—	—	196,000
2023-06-16	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,331 sh	$24.90	+$183K	7,331
2023-06-16	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−7,331 sh	$74.00	−$542K	0
2023-06-16	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,331 sh	—	—	198,000
2023-06-14	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,669 sh	$24.90	+$116K	4,669
2023-06-14	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−509 sh	$72.45	−$36.9K	4,160
2023-06-14	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−971 sh	$73.31	−$71.2K	3,189
2023-06-14	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−2,534 sh	$74.59	−$189K	655
2023-06-14	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−655 sh	$75.49	−$49.4K	0
2023-06-14	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,669 sh	—	—	205,331
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+12K sh	$24.90	+$299K	12,000
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−6,000 sh	$48.16	−$289K	6,000
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−6,000 sh	$48.66	−$292K	0
2023-03-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−12K sh	—	—	210,000
2023-03-02	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+48K sh	—	—	48,000
2023-01-03	COYACoya Therapeutics, Inc.P Purchase	Director	PPurchase	+2,000 sh	—	—	2,000
2023-01-03	COYACoya Therapeutics, Inc. · Warrant to Purchase Common StockP Purchase	Director	PPurchase	+1,000 sh	—	—	1,000
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	$24.90	+$99.6K	4,000
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−4,000 sh	$62.51	−$250K	0
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	222,000
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	$24.90	+$99.6K	4,000
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−3,489 sh	$61.82	−$216K	511
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−511 sh	$62.41	−$31.9K	0
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	226,000
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	$24.90	+$99.6K	4,000
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−4,000 sh	$60.90	−$244K	0
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	230,000
2022-09-15	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	$24.90	+$99.6K	4,000
2022-09-15	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−4,000 sh	$30.00	−$120K	0
2022-09-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	234,000
2022-08-01	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+4,000 sh	$24.90	+$99.6K	4,000
2022-08-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−4,000 sh	$30.52	−$122K	0
2022-08-01	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−4,000 sh	—	—	238,000
2022-07-06	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+8,000 sh	$24.90	+$199K	8,000
2022-07-06	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Chief Medical Officer	SSale	−8,000 sh	$30.00	−$240K	0
2022-07-06	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−8,000 sh	—	—	242,000
2022-02-23	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+85K sh	—	—	85,000

Recent filings

Accepted (ET)
Feb 294
Garren Hideki0000905148-24-000834
SEC(opens sec.gov)
Jan 194
Garren Hideki0001493152-24-003111
SEC(opens sec.gov)
Sep 134
Garren Hideki0000905148-23-000919
SEC(opens sec.gov)
Aug 164
Garren Hideki0001140361-23-040143
SEC(opens sec.gov)
Jul 124
Garren Hideki0001140361-23-034304
SEC(opens sec.gov)
Jun 164
Garren Hideki0001140361-23-030333
SEC(opens sec.gov)
Jun 144
Garren Hideki0001140361-23-029929
SEC(opens sec.gov)

Companies

Address

C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD

SOUTH SAN FRANCISCO, CA, 94080